HWVAX | SSGSX | HWVAX / SSGSX | |
Total Expense Ratio | 1.05 | 1.26 | 83% |
Annual Report Gross Expense Ratio | 1.12 | 1.26 | 89% |
Fund Existence | 11 years | 27 years | - |
Gain YTD | 1.800 | 1.378 | 131% |
Front Load | 5% | 6% | 91% |
Min. Initial Investment | 2500 | 2500 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 815M | 5.52B | 15% |
Annual Yield % from dividends | 0.65 | 0.48 | 136% |
Returns for 1 year | -0.75 | -3.20 | 23% |
Returns for 3 years | 6.22 | 3.97 | 157% |
Returns for 5 years | 58.70 | 27.06 | 217% |
Returns for 10 years | 44.40 | 23.80 | 187% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
DFLVX | 54.38 | 0.39 | +0.72% |
DFA US Large Cap Value I | |||
NBHRX | 15.29 | 0.09 | +0.59% |
Neuberger Berman Equity Income R3 | |||
MRIMX | 24.85 | 0.11 | +0.44% |
Victory Integrity Mid-Cap Value R6 | |||
GEMIX | 29.99 | 0.11 | +0.37% |
Goldman Sachs Emerging Markets Eq Instl | |||
BMPEX | 28.21 | 0.07 | +0.25% |
Beck Mack + Oliver Partners |